Filter
1298
Text search:
Manufacturing
Featured
Recommendations
107
New Publications
302
Language
Document type
No document type
584
Studies & Reports
283
Guidelines
189
Strategic & Response Plan
78
Manuals
71
Fact sheets
53
Situation Updates
13
Training Material
11
Resource Platforms
8
Brochures
4
Infographics
2
Online Courses
1
Videos
1
Countries / Regions
Global
72
India
52
Kenya
43
Uganda
26
Sierra Leone
25
Nigeria
25
Ghana
25
Africa
24
Nepal
23
Ethiopia
22
Rwanda
20
Western and Central Europe
20
South Africa
19
Zambia
18
Tanzania
17
Myanmar / Burma
17
Namibia
16
Bangladesh
15
Liberia
14
Ukraine
14
Lesotho
14
Philippines
13
Syria
13
Malawi
13
West and Central Africa
13
South–East Asia Region
12
East and Southern Africa
11
Botswana
10
Zimbabwe
9
Guinea
8
Latin America and the Carribbean
8
Indonesia
7
Eswatini/ Swaziland
7
Congo, Democratic Republic of
6
Haiti
6
Pakistan
5
Middle East and North Africa
5
Asia
5
Eastern Europe
5
Russia
5
USA
4
South Sudan
4
Cambodia
4
Thailand
4
Mozambique
4
Sri Lanka
4
Cameroon
3
Jordan
3
Germany
3
Yemen
3
Eastern Europe and Central Asia
3
Albania
3
Tajikistan
3
Moldova
3
Senegal
2
Afghanistan
2
China
2
Sudan
2
Benin
2
Colombia
2
Western Pacific Region
2
Laos
2
Vietnam
2
Turkmenistan
2
Mauritius
2
United Kingdom
2
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Turkey
1
Egypt
1
Chad
1
Argentina
1
Brazil
1
Serbia
1
Ecuador
1
Angola
1
Madagascar
1
Solomon Islands
1
Venezuela
1
Uzbekistan
1
Australia
1
Kazakhstan
1
Maldives
1
Belarus
1
Bosnia and Herzegovina
1
Authors & Publishers
Publication Years
Category
Countries
472
Clinical Guidelines
75
Key Resources
61
Public Health
57
Pharmacy & Technologies
45
Women & Child Health
25
Capacity Building
10
Toolboxes
COVID-19
161
Pharmacy
99
AMR
90
HIV
80
Planetary Health
75
TB
42
Mental Health
41
Ebola & Marburg
31
NTDs
31
Malaria
30
Health Financing Toolbox
27
Conflict
26
Global Health Education
24
Disability
23
Rapid Response
22
NCDs
21
Specific Hazards
18
Natural Hazards
16
2.0 Rapid Response
16
Polio
9
Refugee
9
Caregiver
9
Cholera
8
Zika
3
Typhoon
1
This WHO information note provides an updated list of recommended criteria for selecting RDTs for malaria, and highlights the performance of RDTs evaluated by the WHO malaria RDT product testing programme. It also provides an overview of additional considerations in the procurement of rapid tests.
High prices, hard-to-access human insulin, few insulin producers, and weak health systems are just some of the barriers that people with diabetes face a century after insulin was discovered, WHO notes in a new report
Multi-country outbreak of cholera External Situation Report # 23, published 20 February 2025
Dermatological Preparations For The Tropics
recommended
A formulary of dermatological preparations and background information on therapeutic choices, production and dispensing. 2nd edition
Summary of the Ethopian country office of WHO on COVID-19 activities.
Issue Brief 31: Antimicrobial resistance (AMR) can occur when viruses, bacteria, parasites and fungi change over time. There is no longer a response to medicines, and the infection treatment gets really difficult which increases the risk of a disesase spread, which can lead to severe health problems
...
10 May 2021. Manufactureres:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
The ChAdOx1-S/nCoV-19 [recombinant] vaccine is a replication-deficient adenoviral vecto
...
WHO Model Formulary for Children
recommended
WHO Model Formulary for children based on the Second Model List of Essential Medicines for Children 2009.
In 2007, the World Health Assembly passed a Resolution titled ‘Better Medicines for Children’. This resolution recognized the need for research and development into medicines for children,
...
First edition, November 1997 | Revised July 2002
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized i
...
WHO/UNICEF/UNFPA joint statement
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment
...
The workshop is structured around 13 learning modules. The first module (Introduction) gives an overview of WSPs. The last module (Module 12) introduces participants to the quality assurance tool for WSPs (WHO & IWA, 2012). Modules 1–11 relate explicitly to the WSP manual produced by IWA and WHO (
...
CEPI is seeking to raise $3.5 billion to implement CEPI’s next 5-year plan. To mitigate the immediate threat of COVID-19 variants, it is activating key elements of this plan now—and seeking to mobilise a portion of this $3.5 billion in 2021. We have already launched R&D programmes to initiate de
...
The training is targeted at all professionals involved in the management of drinking-water safety. The handbook is divided into three parts:
• Part 1 – Overview of the training approach, training structure and mode of training assessment
• Part 2 – Module learning material, which i ...
• Part 1 – Overview of the training approach, training structure and mode of training assessment
• Part 2 – Module learning material, which i ...
This article is part two in a series of explainers on vaccine development and distribution. Part one focused on how vaccines work to protect our bodies from disease-carrying germs. This article focuses on the ingredients in a vaccine and the three clinical trial phases. Part three outlines the nex
...
Global UNIDO Project: Strengthening the local production of essential generic drugs in the least developed and developing countries
PQM conducted an assessment of the medicine quality assurance and quality control systems in Rwanda during November 9-13, 2009. Medicine quality assurance remains to be developed in Rwanda: the country has neither a medicine regulatory authority (MRA) nor a national medicine quality control laborato
...
